139 related articles for article (PubMed ID: 9636514)
1. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
[No Abstract] [Full Text] [Related]
2. The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation.
van Duijnhoven E; Christiaans M; Undre N; Stevenson P; van Hooff J
Transplant Proc; 1998 Jun; 30(4):1268-70. PubMed ID: 9636515
[No Abstract] [Full Text] [Related]
3. Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation.
Zanker B; Sohr B; Eder M; Frohmann E; Land W
Transplant Proc; 1999; 31(1-2):1167. PubMed ID: 10083521
[No Abstract] [Full Text] [Related]
4. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
Undre NA; Schäfer A
Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
[No Abstract] [Full Text] [Related]
6. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
[No Abstract] [Full Text] [Related]
7. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.
Salazar A; McAlister VC; Kiberd BA; Bitter-Suermann H; Al-Kerithy MF; MacDonald AS
Transplant Proc; 2001; 33(1-2):1038-9. PubMed ID: 11267181
[No Abstract] [Full Text] [Related]
8. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
[No Abstract] [Full Text] [Related]
9. Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.
Burke GW; Ricordi C; Karatzas T; Carreno M; Markou M; Cirocco R; Ciancio G; Qian T; Selvaggi G; Alejandro R; Skyler JS; Roth D; Tzakis A; Miller J
Transplant Proc; 1997; 29(1-2):1207-8. PubMed ID: 9123275
[No Abstract] [Full Text] [Related]
10. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
Hu RH; Lee PH; Tsai MK
Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
[No Abstract] [Full Text] [Related]
11. Can we improve the results of simultaneous pancreas-kidney transplantation?
Fornairon S; Desgrandchamps F; Cattan P; Meria P; Anidjar M; Bedrossian J; Teillac P; Le Duc A; Legendre C
Transplant Proc; 1998 Sep; 30(6):2818-9. PubMed ID: 9745580
[No Abstract] [Full Text] [Related]
12. Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation.
Rigotti P; Baldan N; Cadrobbi R; Furian L; Sarzo G; Dall'Olmo L; Ancona E
Transplant Proc; 2002 Aug; 34(5):1906-8. PubMed ID: 12176623
[No Abstract] [Full Text] [Related]
13. Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin.
Schulz T; Martin D; Heimes M; Klempnauer J; Buesing M
Transplant Proc; 1998 Jun; 30(4):1533-5. PubMed ID: 9636623
[No Abstract] [Full Text] [Related]
14. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Serafinowicz A; Gaciong Z; Baçzkowska T; Durlik M; Lao M
Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
[No Abstract] [Full Text] [Related]
15. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
Oellerich M; Armstrong VW; Schütz E; Shaw LM
Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
[No Abstract] [Full Text] [Related]
16. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
[No Abstract] [Full Text] [Related]
17. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
Wadhawan S; Jauhari H; Singh S
Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891
[No Abstract] [Full Text] [Related]
18. Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation?
Boots JM; Christiaans MH; Undre NA; van Hooff JP
Transplant Proc; 2002 Dec; 34(8):3171-2. PubMed ID: 12493409
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of tacrolimus: clinically relevant aspects.
Undre NA; Stevenson P; Schäfer A
Transplant Proc; 1999 Nov; 31(7A):21S-24S. PubMed ID: 10576037
[No Abstract] [Full Text] [Related]
20. Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics.
Eghtesad B; Malhotra D; Hecker WP; Haq M; Gibel LJ; Wheeler D; Smith AY; Harford AM
Transplant Proc; 1998 Jun; 30(4):1232-3. PubMed ID: 9636500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
